Vident Investment Advisory, LLC Meridian Bioscience Inc Transaction History

Vident Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $2.18 Million - $2.37 Million	70,694 New	70,694 $2.23 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $555,085 - $753,875	-38,229 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $162,295 - $178,689	10,929 Added 40.03%	38,229 $570,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $78,384 - $95,424	5,680 Added 26.27%	27,300 $434,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $84,069 - $98,690	6,092 Added 39.23%	21,620 $318,000
Q4 2017 Feb 15, 2018	BUY	$13.55 - $15.8 $210,404 - $245,342	15,528	15,528 $217,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.